XML 30 R14.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Options
12 Months Ended
Dec. 31, 2021
Stock Options [Abstract]  
STOCK OPTIONS

8. STOCK OPTIONS

 

On April 26, 2018 at the Company’s annual meeting, the Company’s stockholders approved the FlexShopper, Inc. 2018 Omnibus Equity Compensation Plan (the “2018 Plan”). Upon the 2018 Plan’s approval, approximately 1,057,000 shares of Company common stock were available for issuance thereunder. The 2018 Plan replaced the Prior Plans. No new awards will be granted under the Prior Plans; however, awards outstanding under the Prior Plans upon approval of the 2018 Plan remain subject to and will be settled with shares under the applicable Prior Plan.

 

On February 21, 2019, the Company’s Board of Directors approved Amendment No. 1 to the 2018 Plan, subject to stockholder approval. On May 2, 2019, the Company’s stockholders approved the 2018 Plan Amendment that increased (a) the total number of shares available for issuance under the 2018 Plan by 1,000,000 shares and (b) the number of shares available for issuance as “incentive stock options” within the meaning of Internal Revenue Code Section 422 by 1,000,000 shares. 

 

On April 24, 2020, the Company’s Board of Directors approved an Amendment No. 2 to the 2018 Plan, subject to stockholder approval. On June 10, 2020, the Company’s stockholders approved the 2018 Plan Amendment that increased (a) the total number of shares available for issuance under the 2018 Plan by 1,000,000 shares and (b) the number of shares available for issuance as “incentive stock options” within the meaning of Internal Revenue Code Section 422 by 1,000,000 shares.

 

On March 3, 2021, the Company’s Board of Directors approved an Amendment No. 3 to the 2018 Plan, subject to stockholder approval. On June 9, 2021, the Company’s stockholders approved the 2018 Plan Amendment that increased (a) the total number of shares available for issuance under the 2018 Plan by 2,000,000 shares and (b) the number of shares available for issuance as “incentive stock options” within the meaning of Internal Revenue Code Section 422 by 2,000,000 shares.

 

Grants under the 2018 Plan and the Prior Plans consist of incentive stock options, non-qualified stock options, stock appreciation rights, stock awards, stock unit awards, dividend equivalents and other stock-based awards. Employees, directors and consultants and other service providers are eligible to participate in the 2018 Plan and the Prior Plans. Options granted under the 2018 Plan and the Prior Plans vest over periods ranging from immediately upon grant to a five-year period and expire ten years from date of grant.

 

As of December 31, 2021, approximately 2,457,000 shares remained available for issuance under the 2018 Plan.

 

Activity in stock options for the year ended December 31, 2021 and December 31, 2020 was as follows:

 

   Number of
options
   Weighted
average
exercise
price
   Weighted
average
contractual
term
(years)
   Aggregate
intrinsic
value
 
Outstanding at January 1, 2021   2,595,700   $1.92    
 
   $2,491,026 
Granted   626,238    2.52         74,482 
Exercise   (82,333)   0.83         151,544 
Forfeited   (58,701)   2.65         58,285 
Outstanding at December 31, 2021   3,080,904   $2.06    6.7   $1,923,642 
Vested and exercisable at December 31, 2021   2,307,571   $2.04    6.9   $1,674,967 
                     
Outstanding at January 1, 2020   2,004,318   $1.72    
 
   $2,542,361 
Granted   860,465    2.38         
 
 
Exercised   (7,166)   0.79         6,523 
Forfeited   (261,917)   1.90         134,070 
Outstanding at December 31, 2020   2,595,700   $1.92    7.60   $2,491,026 
Vested and exercisable at December 31, 2020   1,730,198   $1.90    7.82   $
1.967,071
 

 

The weighted average grant date fair value of options granted during twelve-month period ended December 31, 2021 and December 31, 2020 was $1.75 and $1.47 per share respectively. The Company measured the fair value of each option award on the date of grant using the Black-Scholes-Merton (BSM) pricing model with the following weighted average assumptions:

  

    2021     2020  
Exercise price   $ 2.52     $ 2.38  
Expected life     5 years       5 years  
Expected volatility     91.2 %     76 %
Dividend yield     0 %     0 %
Risk-free interest rate     0.57%       1.07%  

 

The expected dividend yield is based on the Company’s historical dividend yield. The expected volatility is based on the historical volatility of the Company’s common stock. The expected life is based on the simplified expected term calculation permitted by the Securities and Exchange Commission (the “SEC”), which defines the expected life as the average of the contractual term of the options and the weighted-average vesting period for all option tranches. The risk-free interest rate is based on the annual yield on the grant date of a zero-coupon U.S. Treasury bond the maturity of which equals the option’s expected life.

 

The fair value of stock options is recognized as compensation expense by the straight-line method over the vesting period. Compensation expense recorded was $1,125,819 and $981,261 for the year ended December 31, 2021 and December 31, 2020, respectively. Unrecognized compensation cost related to non-vested options at December 31, 2021 amounted to approximately $802,271, which is expected to be recognized over a weighted average period of 2.8 years.